Vas Narasimhan tapped to take Novartis' helm as Joe Jimenez heads to Silicon Valley
⇨ Novartis announced Monday that Joe Jimenez is stepping down in February and handing the reins over to 41-year-old Vas Narasimhan, an exuberant advocate of cutting-edge science who’s been making his mark with a slate of successful programs for the company’s next wave of blockbuster drugs. Narasimhan is now joining one of the most exclusive clubs in biopharma — CEO of a biopharma organization with activities that span the globe. In naming him CEO, the Basel-based company is keeping an American at the top. But instead of the marketing or legal background of most of his peers, Narasimhan brings experience in new product development. Jimenez, meanwhile, has his eye on a place in Silicon Valley.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.